Neogliptin
General
Type : Gliptin,Trifluoro,Cyanide,Azabicyclo
Chemical_Nomenclature : (3S)-2-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-2-azabicyclo[2.2.1]heptane-3-carbonitrile
Canonical SMILES : C1CC2CC1C(N2C(=O)CC(CC3=CC(=C(C=C3F)F)F)N)C#N
InChI : InChI=1S\/C17H18F3N3O\/c18-13-7-15(20)14(19)5-10(13)3-11(22)6-17(24)23-12-2-1-9(4-12)16(23)8-21\/h5,7,9,11-12,16H,1-4,6,22H2\/t9?,11-,12?,16-\/m1\/s1
InChIKey : OYLYPTNUUUUZJU-MWDCTBBTSA-N
Other name(s) : 12a,(3S)-2-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-exo-2-azabicyclo[2.2.1]hepnane-3-carbonitrile p-toluenesulpfonate
MW : 337.34
Formula : C17H18F3N3O
CAS_number :
PubChem : 151410772
UniChem : OYLYPTNUUUUZJU-MWDCTBBTSA-N
IUPHAR :
Wikipedia :
Target
Families : Neogliptin ligand of proteins in family: DPP4N_Peptidase_S9
Stucture :
Protein : human-DPP4
References (1)
| Title : Design, Synthesis and Biological Evaluation of Neogliptin, a Novel 2-Azabicyclo[2.2.1]heptane-Based Inhibitor of Dipeptidyl Peptidase-4 (DPP-4) - Maslov_2022_Pharmaceuticals.(Basel)_15_273 |
| Author(s) : Maslov IO , Zinevich TV , Kirichenko OG , Trukhan MV , Shorshnev SV , Tuaeva NO , Gureev MA , Dahlen AD , Porozov YB , Schioth HB , Trukhan VM |
| Ref : Pharmaceuticals (Basel) , 15 : , 2022 |
| Abstract : Maslov_2022_Pharmaceuticals.(Basel)_15_273 |
| ESTHER : Maslov_2022_Pharmaceuticals.(Basel)_15_273 |
| PubMedSearch : Maslov_2022_Pharmaceuticals.(Basel)_15_273 |
| PubMedID: 35337071 |